Saturday 7 November 2026 Export BBLG’s income statement to Excel — free account

Bone Biologics Corp.

BBLG Healthcare Biotechnology

EPS: +55.3%
Free cash flow: +9.99%

Quarter to September 2026, against a year earlier

0.33 0.01 +3.13%

Follow BBLG

Alert me

Market cap: $1.1M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	(70.17%)	(75.40%)	(54.96%)	(47.49%)
ROA Full definition →		(64.38%)	(70.20%)	(50.55%)	(44.46%)
ROIC Full definition →		(4,680.27%)	(1,340.96%)	0.00%	0.00%
Return on Tangible Assets Full definition →		(57.81%)	(61.20%)	(73.66%)	(47.75%)
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(2.29)	(1.43)	(1.46)	(0.69)
Free Cash Flow Full definition →		(2.69)	(2.57)	(2.63)	(2.57)
Other line items
Cash ROIC Full definition →		(25.12%)	(27.93%)	(33.04%)	(21.34%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.87	0.90	0.91	0.90
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(2.29)	(1.43)	(1.46)	(0.69)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026